PGCM
WST icon

Prescott Group Capital Management’s West Pharmaceutical WST Stock Holding History

Prescott Group Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,000
Closed -$451K – 153
2019
Q4 		$451K Hold
3,000
– – 0.16% 108
2019
Q3 		$425K Hold
3,000
– – 0.13% 117
2019
Q2 		$375K Buy
+3,000
New +$354K 0.09% 132

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Prescott Group Capital Management's WST Position: Q1 2020 in Review

Prescott Group Capital Management sold out of West Pharmaceutical (WST) in Q1 2020, closing a stake of 3,000 shares — an estimated $451K sold.

Prescott Group Capital Management first reported a position in WST in Q2 2019 and held it in 3 quarters. The position peaked at $451K in Q4 2019. 468 funds tracked by Wall St. Rank hold WST as of Q1 2020.

  • Prescott Group Capital Management reported no remaining West Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Prescott Group Capital Management sold 3,000 West Pharmaceutical shares in Q1 2020, an estimated $451K.
  • Prescott Group Capital Management first reported a position in West Pharmaceutical in Q2 2019 and held it in 3 quarters.
  • Prescott Group Capital Management's West Pharmaceutical position peaked at $451K in Q4 2019.
  • 468 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Prescott Group Capital Management's 13F filing for Q1 2020, filed 13 May 2020.